A detailed history of Tilt Investment Management Holdings, Pbc transactions in Eli Lilly & CO stock. As of the latest transaction made, Tilt Investment Management Holdings, Pbc holds 3,271 shares of LLY stock, worth $2.45 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
3,271
Previous 4,132 20.84%
Holding current value
$2.45 Million
Previous $2.22 Billion 14.09%
% of portfolio
2.06%
Previous 1.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $452,188 - $533,070
-861 Reduced 20.84%
3,271 $1.91 Billion
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $165,876 - $194,813
534 Added 14.84%
4,132 $1.38 Billion
Q4 2022

Apr 07, 2023

BUY
$321.55 - $374.67 $1.16 Million - $1.35 Million
3,598 New
3,598 $1.32 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tilt Investment Management Holdings, Pbc Portfolio

Follow Tilt Investment Management Holdings, Pbc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tilt Investment Management Holdings, Pbc, based on Form 13F filings with the SEC.

News

Stay updated on Tilt Investment Management Holdings, Pbc with notifications on news.